Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis von Mansell, Kerry, Bhimji, Hishaam, Eurich, Dean, Mansell, Holly

Volltext

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis von Mansell, Kerry, Bhimji, Hishaam, Eurich, Dean, Mansell, Holly

Volltext

Potential and Realized Cost Savings with the Use of the Biosimilar Grastofil Vs Neupogen von Bhimji, Hishaam, Eurich, Dean, Mansell, Kerry, Mansell, Holly

Volltext

Impact of pharmacist-led medication assessments on opioid utilization von Bhimji, Hishaam, Landry, Eric, Jorgenson, Derek

Volltext

Impact of pharmacist-led medication assessments on medication costs von Jorgenson, Derek, Landry, Eric, Lysak, Katherine, Bhimji, Hishaam

Volltext

Impact of pharmacist-led medication assessments on opioid utilization von Hishaam, Bhimji, Landry, Eric, Jorgenson, Derek

Volltext

Impact of pharmacist-led medication assessments on medication costs von Jorgenson, Derek, Landry, Eric, Lysak, Katherine, Hishaam, Bhimji

Volltext